Xiaoya Wang , Jianwei Xu , Ying Liu , Qin Chen , Rongjie Liu , Qing Zhang , Ying Xiong , Zhanhui Feng , Qian Zheng , Lan Ye
{"title":"VU0360172 exerts anti-inflammatory effect on germinal matrix hemorrhage in neonatal rats via the mGluR5/PI3Kγ/PPARγ pathway","authors":"Xiaoya Wang , Jianwei Xu , Ying Liu , Qin Chen , Rongjie Liu , Qing Zhang , Ying Xiong , Zhanhui Feng , Qian Zheng , Lan Ye","doi":"10.1016/j.jstrokecerebrovasdis.2025.108469","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>This study investigated the neuroprotective and anti-inflammatory effects of the mGluR5-specific positive allosteric modulator VU0360172 on germinal matrix hemorrhage (GMH) in neonatal rats, as well as the pharmacological mechanism pathway that may underlie this anti-inflammatory effect.</div></div><div><h3>Methods</h3><div>A GMH model was established by intracerebral injection of 0.3 U collagenase VII-S in 7-day-old Sprague-Dawley rats. Animals were randomly divided into the following seven groups: (1) Sham, (2) GMH, (3) GMH +VU0360712 (0.75 mg/kg), (4) GMH + VU0360712 (1.5 mg/kg), (5) GMH + VU0360712 (3.0 mg/kg), (6) GMH + VU0360172 (3.0 mg/kg) + MTEP (0.6 mg/kg), and (7) GMH + VU0360172 (3.0 mg/kg) + AS-605240 (1.8 mg/kg). Western blot analysis was conducted on samples collected at 0, 3, 12 and 24 h and 3 and 7 days post-surgery to observe the postoperative changes in metabotropic glutamate receptor 5 (mGluR5). The neuroprotective and anti-inflammatory effects of different doses of VU0360172 (0.75, 1.5, and 3.0 mg/kg) on GMH were evaluated through neurological behavior testing, brain water content, brain hemorrhage volume, hematoxylin and eosin staining, and ELISA. Finally, MTEP and AS-605240 as inhibitors, were administered to explore the inflammatory regulation and microglial polarization regulation of the mGluR5/PI3Kγ/PPARγ pathway.</div></div><div><h3>Results</h3><div>The results demonstrated that mGluR5 levels started to decline as early as 3 hours after GMH and reached a minimum at 24 hours. Compared with the GMH group, treatment with VU0360172 reduced improved neurological deficits, brain edema, and hemorrhage, reduced tissue loss and inflammatory cell infiltration, and alleviated the inflammatory response, with the middle and high doses showing particularly notable effects (<em>P</em> < 0.05). However, both MTEP and AS-605240 reversed the regulatory effects of VU0360172 on the mGluR5/PI3Kγ/PPARγ pathway. Significant reversals in the expression of key inflammatory factors and microglial markers were observed in the MTEP and AS-605240 groups compared to the high-dose VU0360172 group (<em>P</em> < 0.05).</div></div><div><h3>Conclusion</h3><div>VU3060172 has a neuroprotective effect and anti-inflammatory properties on the GMH mouse model. Its anti-inflammatory mechanism may be achieved by activating the mGluR5/PI3Kγ/PPARγ pathway to regulate microglial polarization.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 12","pages":"Article 108469"},"PeriodicalIF":2.1000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke & Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1052305725002460","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
This study investigated the neuroprotective and anti-inflammatory effects of the mGluR5-specific positive allosteric modulator VU0360172 on germinal matrix hemorrhage (GMH) in neonatal rats, as well as the pharmacological mechanism pathway that may underlie this anti-inflammatory effect.
Methods
A GMH model was established by intracerebral injection of 0.3 U collagenase VII-S in 7-day-old Sprague-Dawley rats. Animals were randomly divided into the following seven groups: (1) Sham, (2) GMH, (3) GMH +VU0360712 (0.75 mg/kg), (4) GMH + VU0360712 (1.5 mg/kg), (5) GMH + VU0360712 (3.0 mg/kg), (6) GMH + VU0360172 (3.0 mg/kg) + MTEP (0.6 mg/kg), and (7) GMH + VU0360172 (3.0 mg/kg) + AS-605240 (1.8 mg/kg). Western blot analysis was conducted on samples collected at 0, 3, 12 and 24 h and 3 and 7 days post-surgery to observe the postoperative changes in metabotropic glutamate receptor 5 (mGluR5). The neuroprotective and anti-inflammatory effects of different doses of VU0360172 (0.75, 1.5, and 3.0 mg/kg) on GMH were evaluated through neurological behavior testing, brain water content, brain hemorrhage volume, hematoxylin and eosin staining, and ELISA. Finally, MTEP and AS-605240 as inhibitors, were administered to explore the inflammatory regulation and microglial polarization regulation of the mGluR5/PI3Kγ/PPARγ pathway.
Results
The results demonstrated that mGluR5 levels started to decline as early as 3 hours after GMH and reached a minimum at 24 hours. Compared with the GMH group, treatment with VU0360172 reduced improved neurological deficits, brain edema, and hemorrhage, reduced tissue loss and inflammatory cell infiltration, and alleviated the inflammatory response, with the middle and high doses showing particularly notable effects (P < 0.05). However, both MTEP and AS-605240 reversed the regulatory effects of VU0360172 on the mGluR5/PI3Kγ/PPARγ pathway. Significant reversals in the expression of key inflammatory factors and microglial markers were observed in the MTEP and AS-605240 groups compared to the high-dose VU0360172 group (P < 0.05).
Conclusion
VU3060172 has a neuroprotective effect and anti-inflammatory properties on the GMH mouse model. Its anti-inflammatory mechanism may be achieved by activating the mGluR5/PI3Kγ/PPARγ pathway to regulate microglial polarization.
期刊介绍:
The Journal of Stroke & Cerebrovascular Diseases publishes original papers on basic and clinical science related to the fields of stroke and cerebrovascular diseases. The Journal also features review articles, controversies, methods and technical notes, selected case reports and other original articles of special nature. Its editorial mission is to focus on prevention and repair of cerebrovascular disease. Clinical papers emphasize medical and surgical aspects of stroke, clinical trials and design, epidemiology, stroke care delivery systems and outcomes, imaging sciences and rehabilitation of stroke. The Journal will be of special interest to specialists involved in caring for patients with cerebrovascular disease, including neurologists, neurosurgeons and cardiologists.